Tatva Chintan Approves Capacity Expansion & Debt Limit Increase
Tatva Chintan Pharma Chem Limited's Board of Directors approved a significant capacity expansion for specialty chemicals at their new greenfield unit in Dahej, Gujarat. This expansion aims to strengthen infrastructure and meet growing market demands. Additionally, the board approved an increase in the company's borrowing limits from ₹300 crore to ₹1,000 crore, subject to shareholder approval. The meeting also saw the approval of unaudited financial results for the quarter ended June 30, 2026, and the re-appointment of three key directors: Mr. Chintan Nitinkumar Shah (Managing Director), Mr. Ajaykumar Mansukhlal Patel (Whole-time Director), and Mr. Shekhar Rasiklal Somani (Whole-time Director), each for a three-year term starting February 1, 2027.
Key Highlights
- Capacity expansion approved for specialty chemicals at Dahej greenfield unit.
- Borrowing limits increased from ₹300 Cr to ₹1,000 Cr.
- Re-appointment of MD and two Whole-time Directors approved for 3 years.
- Unaudited financial results for Q1 FY27 approved.
- Expansion and debt limit increase subject to member approval.
Price Impact
More from TATVA
Tatva Chintan Pharma Chem Board Approves Financials, Director Re-appointments, Expansion
Tatva Chintan Pharma Chem Board Approves Capacity Expansion & Debt Limit Hike
Tatva Chintan Q1: consolidated PAT more than doubles to ₹16 Cr, revenue up 43% YoY